SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-002715
Filing Date
2018-03-16
Accepted
2018-03-16 17:07:47
Documents
84
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K azrx10k123117.htm 10-K 1523142
2 CONSENTS OF EXPERTS AND COUNSEL ex23.htm EX-23 4308
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 17137
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 17399
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 10671
  Complete submission text file 0001654954-18-002715.txt   4493877

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT azrx-20171231.xml EX-101.INS 581880
7 XBRL TAXONOMY EXTENSION SCHEMA azrx-20171231.xsd EX-101.SCH 60100
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20171231_cal.xml EX-101.CAL 57594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20171231_def.xml EX-101.DEF 129312
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20171231_lab.xml EX-101.LAB 305661
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20171231_pre.xml EX-101.PRE 257994
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-37853 | Film No.: 18696546
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1